ES2176302T3 - Sitios de union upa en el dominio 2+3 de upar y anticuerpos reactivos con los mismos. - Google Patents

Sitios de union upa en el dominio 2+3 de upar y anticuerpos reactivos con los mismos.

Info

Publication number
ES2176302T3
ES2176302T3 ES95610039T ES95610039T ES2176302T3 ES 2176302 T3 ES2176302 T3 ES 2176302T3 ES 95610039 T ES95610039 T ES 95610039T ES 95610039 T ES95610039 T ES 95610039T ES 2176302 T3 ES2176302 T3 ES 2176302T3
Authority
ES
Spain
Prior art keywords
par
antibody
dsm
relates
upar
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95610039T
Other languages
English (en)
Inventor
Ulrich Pessara
Ulrich Weidle
Bernhard Kinig
Ulrich Kohnert
Ilse Bartke
Keld Dano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Cancerforskningsfondet af 1989
Original Assignee
Roche Diagnostics GmbH
Cancerforskningsfondet af 1989
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics GmbH, Cancerforskningsfondet af 1989 filed Critical Roche Diagnostics GmbH
Application granted granted Critical
Publication of ES2176302T3 publication Critical patent/ES2176302T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

EL INVENTO SE REFIERE A UN ANTICUERPO QUE INHIBE LA UNION ENTRE U-PA Y U-PAR HASTA UN PORCENTAJE DE UN 90% COMO MINIMO EN UN ENSAYO COMO EL DEFINIDO EN LA ESPECIFICACION, O UN FRAGMENTO ACTIVO O EQUIVALENTE INMUNOLOGICO DE DICHO ANTICUERPO. SE HAN DEPOSITADO MUESTRAS DE LOS CITADOS ANTICUERPOS EL 7 DE JULIO EN EL DEUTSCHE SAMMLUNG VON MIKROORGANISMEN UND ZELLKULTUREN (DSM) CON LOS NUMEROS DE REFERENCIA DSM ACC2178 Y DSM ACC2179 BAJO LOS TERMINOS Y CONDICIONES ESTABLECIDOS EN EL TRATADO DE BUDAPEST. EL INVENTO SE REFIERE ADEMAS A UN METODO PARA DETECTAR O CUANTIFICAR U-PAR O UNA VARIANTE DE GLUCOSILACION DE U-PAR EN UNA MUESTRA, MEDIANTE EL USO DE UN ANTICUERPO SEGUN EL INVENTO. ADEMAS, EL INVENTO SE REFIERE A UN METODO PARA LA FABRICACION DE UN AGENTE TERAPEUTICO PARA PREVENIR O CONTRARRESTAR LA ACTIVIDAD PROTEOLITICA UTILIZANDO EL ANTICUERPO DEL INVENTO, ASI COMO EL USO DE UN ANTICUERPO SEGUN EL INVENTO PARA LA PREPARACION DE UN AGENTE DE DIAGNOSTICO QUE SEA CAPAZ DE DETERMINAR EL DIAGNOSTICO DE UNA CELULA QUE CONTENGA U-PAR EN LA SUPERFICIE.
ES95610039T 1994-07-08 1995-06-22 Sitios de union upa en el dominio 2+3 de upar y anticuerpos reactivos con los mismos. Expired - Lifetime ES2176302T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK83194 1994-07-08

Publications (1)

Publication Number Publication Date
ES2176302T3 true ES2176302T3 (es) 2002-12-01

Family

ID=8098050

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95610039T Expired - Lifetime ES2176302T3 (es) 1994-07-08 1995-06-22 Sitios de union upa en el dominio 2+3 de upar y anticuerpos reactivos con los mismos.

Country Status (7)

Country Link
US (1) US6025142A (es)
EP (1) EP0691350B1 (es)
JP (1) JP2852192B2 (es)
AT (1) ATE217013T1 (es)
CA (1) CA2153208A1 (es)
DE (1) DE69526542T2 (es)
ES (1) ES2176302T3 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6077508A (en) * 1998-03-23 2000-06-20 American Diagnostica Inc. Urokinase plasminogen activator receptor as a target for diagnosis of metastases
WO2002009753A1 (en) * 2000-08-02 2002-02-07 H:S Hvidovre Hospital Composition and method for the treatment or prevention of hiv infection
EP1393743A1 (en) * 2001-01-25 2004-03-03 Fondazione Centro San Raffaele Del Monte Tabor Agents modulating UPA/UPAR activity for the treatment of AIDS
ATE361096T1 (de) * 2001-01-25 2007-05-15 San Raffaele Centro Fond Antikörper zur modulierung der upa/upar interaktion und deren verwendungen
WO2004037286A2 (en) * 2002-10-23 2004-05-06 F. Hoffmann-La Roche Ag Combination of a trioxopyrimidine compound inhibitor and an anti-tumor agent, and uses thereof
DE10323898A1 (de) 2003-05-26 2004-12-23 Wilex Ag Hydroxyamidin- und Hydroxyguanidin-Verbindungen als Urokinase-Hemmstoffe
TW200813091A (en) * 2006-04-10 2008-03-16 Amgen Fremont Inc Targeted binding agents directed to uPAR and uses thereof
PL2117571T3 (pl) * 2006-12-08 2017-08-31 Monopar Therapeutics Inc. Epitop receptora aktywatora plazminogenu typu urokinazy
WO2011123029A1 (en) 2010-03-30 2011-10-06 Ge Healthcare Bio-Sciences Ab Method for determination of binding stoichiometry

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5327493A (en) 1976-08-27 1978-03-14 Risei Ui Ultra micro analysis for acetone and kit for carrying out the analysis
US5519120A (en) * 1989-04-07 1996-05-21 Cancerforskningsfondet Af 1989 Urokinase-type plasminogen activator receptor antibodies
WO1992007083A1 (en) * 1990-10-18 1992-04-30 Cancerforskningsfondet Af 1989 Antibodies against the urokinase receptor and their use
DE69033653T2 (de) * 1989-04-07 2001-06-07 Cancerforskningsfonden Af 1989 Plasminogen-aktivator-rezeptor vom urokinasetyp
JPH07501524A (ja) * 1991-11-18 1995-02-16 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン ｕＰＡ−Ｒの検出・分離方法及びｕＰＡのｕＰＡ−Ｒへの結合阻止方法

Also Published As

Publication number Publication date
US6025142A (en) 2000-02-15
ATE217013T1 (de) 2002-05-15
JPH0859700A (ja) 1996-03-05
DE69526542T2 (de) 2003-01-09
CA2153208A1 (en) 1996-01-09
EP0691350B1 (en) 2002-05-02
EP0691350A3 (en) 1996-11-27
EP0691350A2 (en) 1996-01-10
DE69526542D1 (de) 2002-06-06
JP2852192B2 (ja) 1999-01-27

Similar Documents

Publication Publication Date Title
IE872502L (en) Monoclonal molecules which react immunologically with¹apolipoprotein a-1
LU91215I2 (en) Kepivance (palifermin)
ES2176302T3 (es) Sitios de union upa en el dominio 2+3 de upar y anticuerpos reactivos con los mismos.
GR3008027T3 (es)
ATE290083T1 (de) Pestizid-proteine und stämme
AU7826491A (en) Novel bacillus thuringiensis microbes active against nematodes, and genes encoding novel nematode-active toxins cloned from bacillus thuringiensis isolates
NL300135I1 (nl) Prostaglandinen van de F-reeks.
ES2037341T3 (es) Un metodo para tratamiento de pasta papelera.
ES296770U (es) Banda de esfera de material elastico para amortiguacion de ruidos en el subsuelo y en tuneles, como de grava.
DE59910335D1 (de) Trittschallisolierte Fussbodendiele
ATE45591T1 (de) Mikroorganismen des stammes phanerochaete chrysosporium und deren verwendung.
ES2094960T5 (es) Construccion de un rail.
SE9904236D0 (sv) Immunoassay
BR9003956A (pt) Producao eficiente de proteases mutantes
FR2759635B1 (fr) Plancher elastique destine notamment a un soufflet de passage
EP0297930A3 (en) Monoclonal antibodies
CA2029276A1 (en) Rail pads
ATE280389T1 (de) Verwendung eines antikörpers zur detektion von basophilen und/oder mastzellen
ES2167289T1 (es) Estructura estabilizada, en particular de tipo balasto y procedimiento de estabilizacion de dicha estructura.
AU4864397A (en) Substructure for a railway vehicle track formed from rails
Gao et al. Behaviour of Mild Steel Under Reverse Strain Fatigue
IT207912Z2 (it) Corpo spugnoso composito per uso domestico costituito da almeno due strati dei quali uno in materiale morbido e l'altro in materiale avente un'azione abrasiva.
GB2289535B (en) Paracetamol phosphate for immunoassays
RU94003895A (ru) Способ упрочнения земляного полотна
AR242834A1 (es) Procedimiento para obtener el nuevo antibiotico s 7481/f-1 extraido de caldos de cultivo de trichoderma polysporum (link ex pers.) rifai.